| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $800K | -77.1% |
| R&D Expense | $28.5M | -7.6% |
| SG&A Expense | $20.7M | -12.5% |
| Operating Income | -$48.5M | +17.8% |
| Pre-tax Income | -$45.7M | +6.9% |
| Income Tax | -$350K | -330.3% |
| Net Income | -$45.3M | +7.9% |
| EPS (Basic) | -$9.64 | -845.1% |
| EPS (Diluted) | -$9.64 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.5M | +140.0% |
| Short-term Investments | $40.8M | -52.0% |
| Current Assets | $140.3M | +10.3% |
| Total Assets | $153.0M | +8.1% |
| Current Liabilities | $11.2M | +4.2% |
| Total Liabilities | $19.8M | +27.4% |
| Stockholders' Equity | $133.1M | +5.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.8M | -4.0% |
| Investing Cash Flow | -$5.8M | +83.3% |
| Financing Cash Flow | $135.5M | +1861.6% |
| -845.1% |